BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 32632488)

  • 1. Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study.
    Zheng J; Feng X; Liang Y; Cai J; Shi Z; Kirih MA; Tao L; Liang X
    Surg Endosc; 2021 Jul; 35(7):3267-3278. PubMed ID: 32632488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of laparoscopic liver resection in patients with hepatocellular carcinoma and portal hypertension: a case-matched study.
    Molina V; Sampson-Dávila J; Ferrer J; Fondevila C; Díaz Del Gobbo R; Calatayud D; Bruix J; García-Valdecasas JC; Fuster J
    Surg Endosc; 2018 May; 32(5):2345-2354. PubMed ID: 29218665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic and open minor liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a multicenter study using inverse probability weighting approach.
    Shinkawa H; Kaibori M; Kabata D; Nakai T; Ueno M; Hokuto D; Ikoma H; Iida H; Komeda K; Tanaka S; Kosaka H; Nobori C; Hayami S; Yasuda S; Morimura R; Mori H; Kagota S; Kubo S; Ishizawa T
    Surg Endosc; 2024 Feb; 38(2):757-768. PubMed ID: 38052887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of laparoscopic hepatectomy in patients with hepatocellular carcinoma and portal hypertension: interim analysis of an open prospective study.
    Lim C; Osseis M; Lahat E; Doussot A; Sotirov D; Hemery F; Lantéri-Minet M; Feray C; Salloum C; Azoulay D
    Surg Endosc; 2019 Mar; 33(3):811-820. PubMed ID: 30003350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study.
    Xia F; Zhang Q; Ndhlovu E; Zheng J; Yuan M; Gao H; Xia G
    Surg Endosc; 2024 Feb; 38(2):799-812. PubMed ID: 38062182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic liver resection for hepatocellular carcinoma complicated with significant portal hypertension: A propensity score-matched survival analysis.
    Guo ZY; Hong Y; Tu B; Cheng Y; Wang XM
    Hepatobiliary Pancreat Dis Int; 2023 Aug; 22(4):358-365. PubMed ID: 35370090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic Liver Resection for Hepatocellular Carcinoma in Child-Pugh A Patients With and Without Portal Hypertension: A Multicentre Study.
    Casellas-Robert M; Lim C; Lopez-Ben S; Lladó L; Salloum C; Codina-Font J; Comas-Cufí M; Ramos E; Figueras J; Azoulay D
    World J Surg; 2020 Nov; 44(11):3915-3922. PubMed ID: 32661688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: a systematic review and meta-analysis.
    Xiang ZQ; Wu YC; Qu XL; Luo DJ; Liang H; Ameer S; Long ZT; Dai XM; Zhu Z
    World J Surg Oncol; 2024 Jan; 22(1):3. PubMed ID: 38166925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic versus open limited liver resection for hepatocellular carcinoma with liver cirrhosis: a propensity score matching study with the Hiroshima Surgical study group of Clinical Oncology (HiSCO).
    Yamamoto M; Kobayashi T; Oshita A; Abe T; Kohashi T; Onoe T; Fukuda S; Omori I; Imaoka Y; Honmyo N; Ohdan H
    Surg Endosc; 2020 Nov; 34(11):5055-5061. PubMed ID: 31828498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minor laparoscopic liver resection for Hepatocellular Carcinoma is safer than minor open resection, especially for less compensated cirrhotic patients: Propensity score analysis.
    Di Sandro S; Bagnardi V; Najjar M; Buscemi V; Lauterio A; De Carlis R; Danieli M; Pinotti E; Benuzzi L; De Carlis L
    Surg Oncol; 2018 Dec; 27(4):722-729. PubMed ID: 30449499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: a multi-centre propensity score-based analysis.
    Nomi T; Hirokawa F; Kaibori M; Ueno M; Tanaka S; Hokuto D; Noda T; Nakai T; Ikoma H; Iida H; Komeda K; Ishizaki M; Hayami S; Eguchi H; Matsumoto M; Morimura R; Maehira H; Sho M; Kubo S
    Surg Endosc; 2020 Feb; 34(2):658-666. PubMed ID: 31093748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Laparoscopic Liver Resection for Patients with Multiple Hepatocellular Carcinomas Meeting the Milan Criteria: A Propensity Score-Matched Analysis.
    Peng Y; Liu F; Xu H; Lan X; Wei Y; Li B
    J Laparoendosc Adv Surg Tech A; 2019 Sep; 29(9):1144-1151. PubMed ID: 31411541
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term perioperative outcomes of pure laparoscopic liver resection versus open liver resection for hepatocellular carcinoma: a retrospective study.
    Yoon YI; Kim KH; Cho HD; Kwon JH; Jung DH; Park GC; Song GW; Ha TY; Lee SG
    Surg Endosc; 2020 Feb; 34(2):796-805. PubMed ID: 31161292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of concurrent splenectomy and esophagogastric devascularization on surgical outcomes of partial hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: A multicenter propensity score matching analysis.
    Chen ZL; Yao LQ; Pu JL; Wu H; Xu XF; Chen TH; Zhou YH; Wang H; Chen ZY; Sun LY; Diao YK; Zhong JH; Lau WY; Pawlik TM; Huang DS; Shen F; Liang YJ; Yang T
    Eur J Surg Oncol; 2022 May; 48(5):1078-1086. PubMed ID: 34838392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact and outcomes of liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension.
    Cortese S; Tellado JM
    Cir Cir; 2022; 90(5):579-587. PubMed ID: 36327469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prospective Study Using Propensity Score Matching to Compare Long-term Survival Outcomes After Robotic-assisted, Laparoscopic, or Open Liver Resection for Patients With BCLC Stage 0-A Hepatocellular Carcinoma.
    Zhu P; Liao W; Zhang WG; Chen L; Shu C; Zhang ZW; Huang ZY; Chen YF; Lau WY; Zhang BX; Chen XP
    Ann Surg; 2023 Jan; 277(1):e103-e111. PubMed ID: 35081573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes following laparoscopic versus open major hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score-matched analysis.
    Xu HW; Liu F; Li HY; Wei YG; Li B
    Surg Endosc; 2018 Feb; 32(2):712-719. PubMed ID: 28726140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinically significant portal hypertension after liver resection?
    Qin L; Li C; Xie F; Wang Z; Wen T
    Biosci Trends; 2020 Sep; 14(4):297-303. PubMed ID: 32641640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term surgical outcomes in patients with hepatocellular carcinoma undergoing laparoscopic vs. open liver resection: A retrospective and propensity score-matched study.
    Lee DH; Kim D; Park YH; Yoon J; Kim JS
    Asian J Surg; 2021 Jan; 44(1):206-212. PubMed ID: 32532684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic Liver Surgery: What Are the Advantages in Patients with Cirrhosis and Portal Hypertension? Systematic Review and Meta-Analysis with Personal Experience.
    Coletta D; De Padua C; Parrino C; De Peppo V; Oddi A; Frigieri C; Grazi GL
    J Laparoendosc Adv Surg Tech A; 2020 Oct; 30(10):1054-1065. PubMed ID: 32707003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.